Jingjing Qian (J Qian)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 27

Top Topics

Atrial Fibrillation

Venous Thromboembolism

Breast Cancer Risk

Drug Administration

Top Venues

Journal of thrombosis and thrombolysis

Cardiovascular toxicology

Expert opinion on drug safety

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Cong Bang Truong, Lori Hornsby, Brent Fox, Chiahung Chou, Jingyi Zheng, Jingjing Qian
Benefit and risk of oral anticoagulant initiation strategies in patients with atrial fibrillation and cancer: a target trial emulation using the SEER-Medicare database. Journal of thrombosis and thrombolysis 57 (4) (2024)
Cong Bang Truong, Lori Hornsby, Brent Fox, Chiahung Chou, Jingyi Zheng, Jingjing Qian
Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Cancer: A Target Trial Emulation from SEER-Medicare Database. Cardiovascular drugs and therapy (2024)
Cong Bang Truong, Jingyi Zheng, Lori Hornsby, Brent Fox, Chiahung Chou, Jingjing Qian
Development and Validation of Machine Learning Algorithms to Predict 1-Year Ischemic Stroke and Bleeding Events in Patients with Atrial Fibrillation and Cancer. Cardiovascular toxicology 24 (4) (2024)
Xiangzhong Xue, Jingjing Qian
Safety of marketed biosimilar monoclonal antibody cancer treatments in the US: a disproportionality analysis using the food and drug administration adverse event reporting system (FAERS) database. Expert opinion on drug safety (2024)
Cong Bang Truong, Lori Hornsby, Brent Fox, Chiahung Chou, Jingyi Zheng, Jingjing Qian
Benefit and risk of oral anticoagulant initiation strategies in patients with atrial fibrillation and cancer: a target trial emulation using the SEER-Medicare database. Journal of thrombosis and thrombolysis (2024)
Cong Bang Truong, Lori Hornsby, Brent Fox, Chiahung Chou, Jingyi Zheng, Jingjing Qian
Benefit and risk of oral anticoagulant initiation strategies in patients with atrial fibrillation and cancer: a target trial emulation using the SEER-Medicare database. Journal of thrombosis and thrombolysis 57 (4) (2024)
Cong Bang Truong, Lori Hornsby, Brent Fox, Chiahung Chou, Jingyi Zheng, Jingjing Qian
Benefit and risk of oral anticoagulant initiation strategies in patients with atrial fibrillation and cancer: a target trial emulation using the SEER-Medicare database. Journal of thrombosis and thrombolysis 57 (4) (2024)
Cong Bang Truong, Lori Hornsby, Brent Fox, Chiahung Chou, Jingyi Zheng, Jingjing Qian
Benefit and risk of oral anticoagulant initiation strategies in patients with atrial fibrillation and cancer: a target trial emulation using the SEER-Medicare database. Journal of thrombosis and thrombolysis 57 (4) (2024)
Cong Bang Truong, Jingyi Zheng, Lori Hornsby, Brent Fox, Chiahung Chou, Jingjing Qian
Development and Validation of Machine Learning Algorithms to Predict 1-Year Ischemic Stroke and Bleeding Events in Patients with Atrial Fibrillation and Cancer. Cardiovascular toxicology 24 (4) (2024)
Cong Bang Truong, Jingyi Zheng, Lori Hornsby, Brent Fox, Chiahung Chou, Jingjing Qian
Development and Validation of Machine Learning Algorithms to Predict 1-Year Ischemic Stroke and Bleeding Events in Patients with Atrial Fibrillation and Cancer. Cardiovascular toxicology (2024)
Cong Bang Truong, Jingyi Zheng, Lori Hornsby, Brent Fox, Chiahung Chou, Jingjing Qian
Development and Validation of Machine Learning Algorithms to Predict 1-Year Ischemic Stroke and Bleeding Events in Patients with Atrial Fibrillation and Cancer. Cardiovascular toxicology 24 (4) (2024)
Cong Bang Truong, Lori Hornsby, Brent Fox, Chiahung Chou, Jingyi Zheng, Jingjing Qian
Benefit and risk of oral anticoagulant initiation strategies in patients with atrial fibrillation and cancer: a target trial emulation using the SEER-Medicare database. Journal of thrombosis and thrombolysis 57 (4) (2024)
Xiangzhong Xue, Cong Bang Truong, Jingjing Qian
Adverse event reporting of marketed biosimilar and biological monoclonal antibody cancer treatments in the United States. Expert opinion on biological therapy (2023)
Jingjing Qian, Asmita Priyadarshini Khatiwada, Xiangzhong Xue
Did the 2021 federal change in the practice guidelines for the administration of buprenorphine for treating opioid use disorder increase buprenorphine prescription dispensing in Medicaid population? The American journal on addictions (2023)
Jingjing Qian, Bang Truong, Kaniz Afroz Tanni
Factors associated with adherence to medications for lowering breast cancer risk between female Medicare beneficiaries in Alabama and nationwide. Cancer causes & control : CCC (2023)
Cong Bang Truong, Lori Hornsby, Brent I Fox, Chiahung Chou, Jingyi Zheng, Jingjing Qian
Screening for clinically relevant drug-drug interactions between direct oral anticoagulants and antineoplastic agents: a pharmacovigilance approach. Journal of thrombosis and thrombolysis (2023)
N Poudel, Shahariar Mohammed Fahim, Jingjing Qian, Kimberly B Garza, Nathorn Chaiyakunapruk, S Ngorsuraches
Methodological similarities and variations among EQ-5D-5L value set studies: a systematic review. Journal of medical economics 25 (1) (2022)
Kaniz Afroz Tanni, Cong Bang Truong, Sura Almahasis, Jingjing Qian
Safety of Marketed Cancer Supportive Care Biosimilars in the US: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 35 (2) (2021)
Ning Cheng, Joel Farley, Jingjing Qian, Peng Zeng, Chiahung Chou, Richard Hansen
The association of continuity of care and risk of mortality in breast cancer patients with cardiometabolic comorbidities. Journal of psychosocial oncology (2021)
Cong Bang Truong, Spencer H Durham, Jingjing Qian
Comparisons of adverse event reporting for colistin versus polymyxin B using the US Food and Drug Administration Adverse Event Reporting System (FAERS). Expert opinion on drug safety 20 (5) (2021)
Ahmed Ullah Mishuk, Li Chen, Chao Li, Nan Huo, Richard A Hansen, Ilene Harris, Zippora Kiptanui, Jingjing Qian
Patient factors associated with oral generic olanzapine initiation and substitution among Medicaid beneficiaries: a new user cohort study. Current medical research and opinion 37 (4) (2021)
Jingjing Qian, Cong Bang Truong, Kaniz Afroz Tanni
Author's Reply to Joerg Putzke et al. Comment on: "Safety of Marketed Cancer Supportive Care Biosimilars in the US: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database". BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 35 (3) (2021)
Jingjing Qian, Kaniz Afroz Tanni
Real world evidence in effectiveness, safety, and cost savings of generic levothyroxine: a systematic review. Endocrine 74 (2) (2021)
Chao Li, Li Chen, Nan Huo, Ahmed Ullah Mishuk, Richard A Hansen, Ilene Harris, Zippora Kiptanui, Zhong Wang, Jingjing Qian
Generic escitalopram initiation and substitution among Medicare beneficiaries: A new user cohort study. PloS one 15 (4) (2020)
Shahariar Mohammed Fahim, Chiu-Hsieh Paul Hsu, Fang-Ju Lin, Jingjing Qian, Chiahung Chou
Association between prior use of anti-diabetic medication and breast cancer stage at diagnosis. Expert opinion on drug safety 20 (2) (2020)
Nan Huo, Li Chen, Ahmed Ullah Mishuk, Chao Li, Richard A Hansen, Ilene Harris, Zippora Kiptanui, Zhong Wang, Sarah K Dutcher, Jingjing Qian
Generic levothyroxine initiation and substitution among Medicare and Medicaid populations: a new user cohort study. Endocrine 68 (2) (2020)
Jingjing Qian, Richard A Hansen, Daniel Surry, Jennifer Howard, Zippora Kiptanui, Ilene Harris
Disclosure of industry payments to prescribers: industry payments might be a factor impacting generic drug prescribing. Pharmacoepidemiology and drug safety 26 (7) (2017)